Zydus Cadila
Zydus gets approval to conduct Phase II clinical study in patients with CAPS in Australia
Mon, Dec 13, 2021
Drug firm Zydus Cadila on Monday said it has received approval to commence Phase II clinical study of its upcoming product with patients suffering with Cryopyrin-Associated Periodic Syndrome (CAPS) in Australia.
More >
Zydus Cadila's Covid-19 vaccine ZyCoV-D to be used in these seven states initially
Thu, Dec 02, 2021
Zydus Cadila's COVID-19 vaccine ZyCoV-D will initially be used in seven states, including Maharashtra, Tamil Nadu, Uttar Pradesh and West Bengal, which have been recommended to identify the districts with a high number of of beneficiaries who have not received a single dose of a Covid vaccine for its introduction.
More >
Zydus Cadila agrees to reduce its Covid vaccine price to Rs 265 a dose, final decision soon: Sources
Sun, Oct 31, 2021
Zydus Cadila has agreed to bring down the price of its COVID-19 vaccine to Rs 265 a dose following persistent negotiations by the government but a final deal is yet to be reached, sources said on Sunday.
More >
Zydus Cadila vaccine for Covid 19: World's first DNA-based vaccine! What we know so far about 3-DOSE vaccine that can be administered to children aged 12 years and above too
Sat, Aug 21, 2021
Covid 19 new vaccine: The world’s first and India’s indigenously developed DNA based vaccine for COVID-19 will be administered in 3-dose.
More >
'Investment of Rs 3K-5K cr needed to create extra mfg facilities for COVID-19 vaccine'
Tue, Sep 22, 2020
As the world waits expectantly for COVID-19 vaccine, Zydus Cadila Chairman Pankaj R Patel said India would need to invest between Rs 3,000-5,000 crore to create additional facilities for making a huge number of vaccines required for the Indian population
More >
After Bharat Biotech, Zydus COVID-19 vaccine candidate gets nod from Centre for human trials
Fri, Jul 03, 2020
The potential vaccine showed a "strong immune response" in animal studies, and the antibodies produced were able to completely neutralize the wild type virus, Zydus, part of Cadila Healthcare Ltd, said in a statement to Indian stock exchanges.
More >
